## Abstract Drug resistance remains a key obstacle to successful cancer treatment. The implementation of pharmacogenomics is widely proclaimed as a route to revolutionize the face of cancer therapy. Here we discuss the pharmacogenomics of the p53 tumor suppressor and its role in cancer chemosensiti
✦ LIBER ✦
P53 and its molecular basis to chemoresistance in breast cancer
✍ Scribed by Knappskog, Stian; Lønning, Per Eystein
- Book ID
- 120317904
- Publisher
- Informa plc
- Year
- 2012
- Tongue
- English
- Weight
- 361 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1472-8222
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Pharmacogenomics of the p53 tumor suppre
✍
Suxing Liu; W. Robert Bishop; Bimal Dasmahapatra; Yaolin Wang
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 214 KB
👁 1 views
[Advances in Experimental Medicine and B
✍
Yu, Dihua; Hung, Mien-Chie
📂
Article
📅
2007
🏛
Springer New York
🌐
English
⚖ 209 KB
In Breast Cancer Chemosensitivity, a group of world leading experts review critical aspects of resistance to systemic therapy in breast cancer patients. Beginning with a clinical overview of the problem, the book then focuses on the latest findings of molecular mechanisms of drug resistance. Coverag
Mutations in p53, p53 protein overexpres
✍
Pavel Rossner Jr; Marilie D. Gammon; Yu-Jing Zhang; Mary Beth Terry; Hanina Hibs
📂
Article
📅
2008
🏛
Carol Davila University of Medicine Bucharest, Rom
🌐
English
⚖ 490 KB
p53 polymorphism in ovarian and breast c
✍
IanG. Campbell; DianaM. Eccles; Bridget Dunn; Michael Davis; Vivien Leake
📂
Article
📅
1996
🏛
The Lancet
🌐
English
⚖ 328 KB
p53 and its isoforms in cancer
✍
Bourdon, J-C
📂
Article
📅
2007
🏛
Nature Publishing Group
🌐
English
⚖ 193 KB
The molecular epidemiology of P53 gene m
✍
Arndt Hartmann; Hagen Blaszyk; John S. Kovach; Steve S. Sommer
📂
Article
📅
1997
🏛
Elsevier Science
🌐
English
⚖ 669 KB